Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid)

Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid) Publisher Pubmed

Seyfoori A^{1, 2} ; Barough MS^{3, 4} ; Mokarram P^{5, 6} ; Ahmadi M⁷ ; Mehrbod P⁸ ; Sheidary A⁹ ; Madrakian T^{7, 9} ; Kiumarsi M¹⁰ ; Walsh T¹ ; Mcalinden KD¹¹ ; Ghosh CC¹² ; Sharma P¹³ ; Zeki AA^{14, 15} ; Ghavami S^{6, 10, 16, 17} Show All Authors

Seyfoori A^{1, 2}
Barough MS^{3, 4}
Mokarram P^{5, 6}
Ahmadi M⁷
Mehrbod P⁸
Sheidary A⁹
Madrakian T^{7, 9}
Kiumarsi M¹⁰
Walsh T¹
Mcalinden KD¹¹
Ghosh CC¹²
Sharma P¹³
Zeki AA^{14, 15}
Ghavami S^{6, 10, 16, 17}
Akbari M^{1, 18, 19}

Show Affiliations

1. Laboratory for Innovations in Micro Engineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, V8P 5C2, BC, Canada
2. Biomaterials and Tissue Engineering Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, 1517964311, Iran
3. Department of Immunology, Iran University of Medical Sciences, Tehran, 1449614535, Iran
4. ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, 1517964311, Iran
5. Department of Clinical Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, 7134845794, Iran
6. Autophagy Research Center, Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, 7134845794, Iran
7. Department of Analytical Chemistry, Faculty of Chemistry, Bu-Ali Sina University, Hamedan, 6517838695, Iran
8. Influenza and Respiratory Viruses Department, Pasteur Institute of IRAN, Tehran, 1316943551, Iran
9. Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 14155-6451, Iran
10. Department of Human Anatomy and Cell Science, Rady College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, R3E 0J9, MB, Canada
11. Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, 7248, TAS, Australia
12. Roger Williams Medical Center, Immuno-Oncology Institute (Ix2), Providence, 02908, RI, United States
13. Center for Translational Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Jane & Leonard Korman Respiratory Institute, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, 19107, PA, United States
14. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, U.C. Davis Lung Center, Davis School of Medicine, University of California, Davis, Davis, 95817, CA, United States
15. Veterans Affairs Medical Center, Mather, 95817, CA, United States
16. Biology of Breathing Theme, Children Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, R3E 0J9, MB, Canada
17. Research Institute of Oncology and Hematology, Cancer Care Manitoba, University of Manitoba, Winnipeg, R3E 0J9, MB, Canada
18. Biotechnology Center, Silesian University of Technology, Akademicka 2A, Gliwice, 44-100, Poland
19. Center for Advanced Materials and Related Technologies, University of Victoria, Victoria, V8P 5C2, BC, Canada

Source: International Journal of Molecular Sciences Published:2021

Abstract

Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Related Docs

View other Related Docs

1. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)

2. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)

3. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)

4. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

5. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)

6. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)

7. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)

8. The Role of Mucosal Immunity and Recombinant Probiotics in Sars-Cov2 Vaccine Development, Probiotics and Antimicrobial Proteins (2021)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (16)

Seyed Ahmad Seyed Alinaghi (5)

Style	Citing Format
MLA	Seyfoori A, et al.. "Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid)." International Journal of Molecular Sciences, vol. 22, no. 13, 2021, pp. -.
APA	Seyfoori A, Barough MS, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A, Madrakian T, Kiumarsi M, Walsh T, Mcalinden KD, Ghosh CC, Sharma P, Zeki AA, Ghavami S, Akbari M (2021). Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid). International Journal of Molecular Sciences, 22(13), -.
Chicago	Seyfoori A, Barough MS, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A, Madrakian T, et al.. "Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid)." International Journal of Molecular Sciences 22, no. 13 (2021): -.
Harvard	Seyfoori A et al. (2021) 'Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid)', International Journal of Molecular Sciences, 22(13), pp. -.
Vancouver	Seyfoori A, Barough MS, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A, et al.. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid). International Journal of Molecular Sciences. 2021;22(13):-.
BibTex	@article{ author = {Seyfoori A and Barough MS and Mokarram P and Ahmadi M and Mehrbod P and Sheidary A and Madrakian T and Kiumarsi M and Walsh T and Mcalinden KD and Ghosh CC and Sharma P and Zeki AA and Ghavami S and Akbari M}, title = {Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid)}, journal = {International Journal of Molecular Sciences}, volume = {22}, number = {13}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Seyfoori A AU - Barough MS AU - Mokarram P AU - Ahmadi M AU - Mehrbod P AU - Sheidary A AU - Madrakian T AU - Kiumarsi M AU - Walsh T AU - Mcalinden KD AU - Ghosh CC AU - Sharma P AU - Zeki AA AU - Ghavami S AU - Akbari M TI - Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid) JO - International Journal of Molecular Sciences VL - 22 IS - 13 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract